Paradigm Biopharmaceuticals
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Company Activity
NEWS: Tagged in PhosCo runs hard on Tunisian phosphate | 29 Nov 2024 | |
NEW ROLE: Matthew Fry, Non-Executive Director | 07 Aug 2024 | |
ECM DEAL: New deal has been added | 12 Feb 2024 | |
NEW ROLE: Helen Fisher, Non-Executive Director | 13 Apr 2022 | |
NEW ROLE: Amos Meltzer, Non-Executive Director | 22 Dec 2020 | |
NEW ROLE: Christopher Fullerton, Non-Executive Director | 03 Nov 2020 | |
NEW ROLE: Paul Rennie, Executive Director, Managing Director, Executive Chairman | 03 Nov 2020 | |
NEW ROLE: John Gaffney, Non-Executive Director | 03 Nov 2020 | |
NEW ROLE: Donna Skerrett, Executive Director | 03 Nov 2020 |